cAd3 Marburg vaccine
Sponsors
Sabin Vaccine Insitute, Rwanda Biomedical Center, Ethiopian Ministry of Health
Conditions
Marburg Virus DiseaseMarburgvirus
Phase 2
Phase 2 Monovalent Chimpanzee Adenoviral-Vectored Marburg Virus Vaccine in Healthy Adults
Active, not recruitingPACTR202306534727467
Start: 2023-09-26Target: 125Updated: 2026-08-03
A Phase 2 Open-Label Study to Assess Safety and Immunogenicity of an Investigational Monovalent Chimpanzee Adenoviral-Vectored Marburg Virus Vaccine in Adults in an Outbreak Setting
RecruitingPACTR202412708603314
Start: 2024-10-03Target: 1700Updated: 2026-09-14
A Two-Cohort Phase 2, Rapid Response, Open-Label, Randomized Study to Assess Safety, Efficacy and Immunogenicity of an Investigational Monovalent Chimpanzee Adenoviral-Vectored Marburg Virus Vaccine in Adults in an Outbreak Setting
Active, not recruitingPACTR202512762754420
Start: 2025-12-04Target: 5650Updated: 2026-09-14